FDA cleared alpelisib (Piqray), the first PI3K inhibitor to treat breast cancer, to be used in combination with fulvestrant (Faslodex).
First PIK3CA inhibitor treatment approved, along with diagnostic test.
Metastatic breast cancer drug expands treatment to men.
FDA approved a new subcutaneous injection to treat a certain type of early breast cancer.
A combination melanoma treatment that was just approved by FDA is available through select specialty pharmacies.